Raksawan Deenonpoe

Dr. Raksawan Deenonpoe


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2019 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
RDRaksawan Deenonpoe
Raksawan Deenonpoe
PPPokpong Prayong
Pokpong Prayong
NTNATTAKARN THIPPAMOM
NATTAKARN THIPPAMOM
JMJitlada Meephansan
Jitlada Meephansan
KNKesara Na-Bangchang
Kesara Na-Bangchang
Background: Several immunological pathways, particularly skin inflammation via various pro-inflammatory cytokines have been reported to be involved in the pathogenesis and clinical manifestations of psoriasis. The aim of the study was to investigate the potential role of naringin from Citrus maxima (Burm.) Merr and sericin from Bombyx mori combination in the treatment of psoriasis. Inhibitory effects on the expression of mRNA and the production of pro-inflammatory cytokines (TNF-α, IL-6, IL-23, and IL-12p40) were investigated. Methods: Human peripheral blood mononuclear cells (hPBMCs) were isolated from 10 healthy subjects and 10 patients with psoriasis. The hPBMCs from each group were exposed to naringin or sericin alone, and the combination of naringin and sericin. The expression levels of mRNA and the production of all cytokines were determined using quantitative RT-PCR and ELISA, respectively. Results: Naringin/sericin combination significantly decreased the expression of mRNA and the production of all pro-inflammatory cytokines in hPBMCs from patients with psoriasis. The potency of inhibitory activity was markedly higher than naringin or sericin alone. Conclusion: The activity of naringin/sericin combination on down-regulation of these pro-inflammatory cytokines suggested its potential clinical use in psoriasis as well as other inflammation-associated diseases. The combination might be used as a complementary therapy with conventional treatment in psoriasis to improve clinical efficacy and tolerability.

28 April 2023 in Pathology and Oncology Research
Verified
Journal Article
Open access
TKThitima Khonrak
Thitima Khonrak
SWSasithorn Watcharadetwittaya
Sasithorn Watcharadetwittaya
YCYaovalux Chamgramol
Yaovalux Chamgramol
PIPiyapharom Intarawichian
Piyapharom Intarawichian
RDRaksawan Deenonpoe
Raksawan Deenonpoe
Background: Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. The RET gene rearrangements CCDC6::RET and NCOA4::RET are the most common RET gene rearrangements in PTC patients. Different RET::PTC rearrangements are associated with different PTC phenotypes.Methods: Eighty-three formalin-fixed paraffin-embedded (FFPE) PTC samples were examined. The prevalence and expression levels of CCDC6::RET and NCOA4::RET were determined using semi-quantitative polymerase chain reaction (qRT-PCR). The association of these rearrangements with clinicopathological data was investigated.Results: The presence of CCDC6::RET rearrangement was significantly associated with the classic subtype and absence of angio/lymphatic invasion (p < 0.05). While NCOA4::RET was associated with the tall-cell subtype, and presence of angio/lymphatic invasion and lymph node metastasis (p < 0.05). Multivariate analysis demonstrated that an absence of extrathyroidal extension and extranodal extension were independent predictive factors for CCDC6::RET, whereas the tall-cell subtype, large tumor size, angioinvasion, lymphatic invasion and perineural invasion were independent predictive factors for NCOA4::RET (p < 0.05). However, the mRNA expression level of CCDC6::RET and of NCOA4::RET were not significantly associated with clinicopathological data.Conclusion:CCDC6::RET was correlated with an innocent PTC subtype and characteristics, but NCOA4::RET correlated with an aggressive phenotype of PTC. Therefore, these RET rearrangements strongly associated with clinicopathological phenotypes and can be used as predictive markers in PTC patients.

13 May 2022 in Human Pathology
Verified
Journal Article
Closed access
SASudarat Ainthachot
Sudarat Ainthachot
PSPrakasit Sa-Ngiamwibool
Prakasit Sa-Ngiamwibool
MTMalinee Thanee
Malinee Thanee
SWSasithorn Watcharadetwittaya
Sasithorn Watcharadetwittaya
YCYaovalux Chamgramol
Yaovalux Chamgramol
RDRaksawan Deenonpoe
Raksawan Deenonpoe

19 May 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RDRaksawan Deenonpoe
Raksawan Deenonpoe
PSPrakasit Sa-Ngiamwibool
Prakasit Sa-Ngiamwibool
SWSasithorn Watcharadetwittaya
Sasithorn Watcharadetwittaya
MTMalinee Thanee
Malinee Thanee
KIKitti Intuyod
Kitti Intuyod
CPChawalit Pairojkul
Chawalit Pairojkul
Cholangiocarcinoma (CCA) is highly endemic in the Northeast Thailand. Recently, chromosome aberrations provided new insights into pathogenesis of CCA. Therefore, chromosome aberration might be used as a prognostic factor and therapeutic planning of this cancer. This aim of this study is to examine the correlation between an increase of chromosome 7 (C7) and/or 17 (C17) copy number variants (CNVs) with clinicopathological data and the overall survival time (OS) of CCA patients using fluorescence in situ hybridization (FISH) assays. C7 and C17 CNVs were examined using FISH form 157 formalin-fixed paraffin-embedded (FFPE) tissues of CCA patients from Khon Kaen, Thailand between 2011 and 2015. OS was visualized using Kaplan–Meier plot. Univariate and multivariate analyses were used to determine the ability of the clinicopathological parameters to predict OS. C17 > trisomy (odd ratio, 6.944, P < 0.001), C7/17 trisomy (odd ratio; 4.488, P = 0.019), and C7/17 > trisomy (odd ratio; 6.723, P < 0.001) were independently predictive factors for lymph node metastasis. Interestingly, an increase of C7, C17, and C7/17 CNVs in both trisomy and > trisomy was independently correlated with short median OS. An increased of C7 and/or 17 have a potential as a poor prognostic marker in CCA patients.

26 May 2026 in Experimental and Molecular Pathology
Verified
Journal Article
Open access
PAParawee Artbua
Parawee Artbua
NKNaruemon Kentachalee
Naruemon Kentachalee
PSPrakasit Sa-Ngiamwibool
Prakasit Sa-Ngiamwibool
SSSirinya Sitthirak
Sirinya Sitthirak
PWPhongsathorn Wichian
Phongsathorn Wichian
RDRaksawan Deenonpoe
Raksawan Deenonpoe
Cholangiocarcinoma (CCA) is a highly lethal malignancy and often exhibits histological overlap with non-malignant bile duct lesions, including cholangitis and precancerous lesions. The lack of reliable markers to distinguish malignant from non-malignant biliary lesions underscores the need for improved diagnostic approaches. The cGAS-STING pathway, a key regulator of innate immune responses, may provide insight into inflammation-associated carcinogenesis. This study aimed to compare the expression of cGAS, STING, IRF3, and IFN-α among CCA, precancerous lesions, and cholangitis, and to evaluate their potential diagnostic relevance. A total of 198 formalin-fixed paraffin-embedded (FFPE) tissue samples were analyzed, including 164 cases of cholangiocarcinoma, 26 precancerous lesions, and 8 cases of cholangitis. Immunohistochemistry for cGAS, STING, IRF3, and IFN-α was performed, and protein expression was quantitatively assessed using H-scores. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. ROC-derived H-score cut-off values were applied in logistic regression models to assess association with CCA. IRF3 and IFN-α expression were markedly increased in precancerous lesions compared with cholangitis. High cGAS and IRF3 expression at ROC-derived cut-off values showed association with CCA. Logistic regression analysis demonstrated that elevated cGAS (H-score ≥ 202; p = 0.026) and IRF3 (H-score ≥ 201; p = 0.032) expression were associated with increased odds of CCA. Although cGAS and IRF3 showed limited standalone diagnostic accuracy, their ROC-derived H-score thresholds were modestly associated with CCA. This work could provide adjunctive diagnostic information when integrated with routine histopathological assessment.